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Abstract
Several components of honeybee venom are known
to cause allergenic responses in humans and other
vertebrates. One such component, the minor allergen
Api m 6, has been known to show amino acid variation
but the genetic mechanism for this variation is
unknown. Here we show that Api m 6 is derived from a
single locus, and that substantial protein-level varia-
tion has a simple genome-level cause, without the
need to invoke multiple loci or alternatively spliced
exons. Api m 6 sits near a misassembled section of
the honeybee genome sequence, and we propose
that a substantial number of indels at and near Api m
6 might be the root cause of this misassembly. We
suggest that genes such as Api m 6 with coding-region
or untranslated region indels might have had a strong
effect on the assembly of this draft of the honeybee
genome.
Keywords: allelic variation, allergen, Api m 6, bee venom,
signal peptide.
Introduction
 
Dangerous allergenic responses can be caused in humans
by  components of the venom of stinging social insects
(Hoffman, 2003). A major research goal remains to predict
which fraction of the human population will be likely to react
adversely to speciﬁc venom components received through
incidental or occupation-related stinging. Further, an
understanding of the components of venoms that induce
allergic responses can be used to better tune therapeutic
treatments of allergic responses. Allergens from insects
and other sources are designated with the terms ‘major’
or ‘minor’ depending on whether more or less than 50%
of the hypersensitive patients develops a speciﬁc IgE
response against a given allergen (Larsen & Lowenstein,
1996). Honeybee venom contains the major allergens Api
m 1 (phospholipase A2), Api m 2 (hyaluronidase), Api m
3 (acid phosphatase), Api m 4 (melittin) and Api m 7 (CUB
serine protease), along with at least one minor allergen,
Api m 6, which shows 42% IgE responsiveness (Hoffman,
2006).
Here we describe the genomic basis for observed protein-
level heterogeneity found for Api m 6. Api m 6 migrates as
an 8-kDa band in sodium dodecyl sulphate–polyacrylamide
gel electrophoresis and its amino acid sequence was
determined on high-performance liquid chromatography-
puriﬁed preparations (Kettner 
 
et al
 
., 2001). It exists as four
isoforms of 7190, 7400, 7598 and 7808 Da, respectively,
differing in their primary structure at the amino and carboxy
terminus by a maximum of six amino acids (Kettner 
 
et al
 
.,
2001). Allergen heterogeneity can be due to allelic variation
at a single allergen gene (Gao 
 
et al
 
., 2005), the occurrence
of multiple genes of allergens encoding highly homologous
proteins (Piersma 
 
et al
 
., 2005), or by alternative splicing of
a single transcript (Mykles 
 
et al
 
., 1998). Some bee venom
components are already known to have a rather peculiar
gene organization. Indeed, the precursors of bee venom
apamin and MCD peptide are encoded by two genes in
tandem, which share the same 3
 
′
 
-exon (Gmachl & Kreil,
1995). Here we use new genome-level data for honeybees
to determine the cause behind multiple isoforms of Api m
6. We present the complete cDNA sequences for two Api m
6 variants. We then use the latest honeybee assembly to
show that these variants arise from a single polymorphic
locus. Interestingly, high sequence-level variation at and
around this locus appears to be responsible for a break in
the honeybee genome assembly.
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Results and discussion
 
Cloning and sequencing of cDNA fragments encoding 
Api m 6
 
5
 
′
 
-Rapid ampliﬁcation of cDNA ends (5
 
′
 
-RACE) using gene-
speciﬁc primers resulted in an amplicon of approximately
350 bp in size that was cloned in the pCR®4 vector. Trans-
formation to chemically competent TOP-10 
 
Escherichia coli
 
yielded a large number of transformants, 10 of which were
retained for further analysis. DNA sequences were found to
be identical (represented by 
 
clones 5.1
 
) and consisted of a
putative 5
 
′
 
 untranslated region (UTR) and a coding region
for which the predicted protein was identical to that known
for Api m 6. 3
 
′
 
-RACE resulted in a fragment of approximately
the same size, which was again cloned and sequenced.
Here the sequenced clones showed two transcript variants,
represented by the inserts of 
 
clone 3.3
 
 and 
 
clone 3.9
 
. Sub-
sequently, we ampliﬁed the complete Api m 6 transcript from
a venom gland cDNA preparation using primers designed,
respectively, at the extreme 5
 
′
 
- and 3
 
′
 
-ends of 
 
clone 5.1
 
 and
 
clone 3.9
 
. Sequencing of the corresponding 528 bp frag-
ment revealed two additional minor transcript differences,
this time at the 5
 
′
 
-end, 38 and 117 bp upstream of the forward
primer, when compared with the insert of 
 
clone 5.1
 
. This
cDNA sequence was deposited to GenBank (accession
number DQ384991), as was a sequence assembly of the
inserts of 
 
clones 5.1
 
 and 
 
3.9
 
 (accession number DQ384990).
Because the latter matched perfectly well the latest honeybee
genome assembly (see further), it was named variant 1,
whereas DQ384991 became variant 2.
 
Deduced amino acid sequence and protein heterogeneity
 
The deduced amino acid sequences of both transcripts are
given in Fig. 1. At the protein level differences were noticed
at position 14 (Val against Ile) and at the carboxy terminal
region, with two additional residues Leu and Pro. This
corresponds with the differences found at the C-terminal
ends of the four Api m 6 variants described by Kettner 
 
et al
 
.
(2001): Api m 6.01 and Api m 6.03 having the same two
additional residues, in contrast to the variants Api m 6.02
and Api m 6.04. Further we noticed that the deduced amino
acid sequences were 21 residues longer at the N-terminus
when compared with the earlier described variants Api m
6.03 and Api m 6.04 (Kettner 
 
et al
 
., 2001). However, based
on an 
 
in silico
 
 SigP-NN prediction (Bendtsen 
 
et al
 
., 2004), a
signal peptide cleavage site was identiﬁed between position
21 and 22, resulting in a mature protein that starts at exactly
the same residue. Depending on the cDNA variant that was
translated this mature protein will correspond to Api m 6.03
or Api m 6.04. The other two variants described by Kettner
 
et al
 
. (2001) lack the ﬁrst four N-terminal amino acids Phe-
Gly-Gly-Phe of the mature protein. We have found no indica-
tion that this was the result of a new transcript or alternative
splicing variant. Nor could we evidence that the mature
proteins of these variants are shortened by enzymatic
activity similar to step-wise cleavage of the pro part from
promelittin by dipeptidylpeptidase IV (Kreil 
 
et al
 
., 1980). Fur-
ther we notice that amino acid replacement at position 14 in
the deduced amino acid sequence is located in the signal
peptide and has no consequences for the mature allergen.
 
Sequence homology and conserved domains
 
Conserved domain search (Marchler-Bauer & Bryant, 2004)
of the deduced amino acid sequence from transcript variant
Figure 1. Nucleotide and deduced amino acid sequences of Api m 6 
transcript variant 1 (A) and 2 (B). The numbers on the left denote the 
nucleotide numbers. The start and stop codon are underlined. Residues −1 
to −21 are from the signal peptide. Residue +1 denotes the ﬁrst amino acid 
of the mature protein. In (C) the alignment of the deduced amino acid 
sequences of the two Api m 6 transcript variants is given. 
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1 revealed a trypsin inhibitor like cysteine rich (TIL) domain
from residue 37–91 (score: 37.3; 
 
E
 
-value: 5e-04). This family
contains trypsin inhibitors as well as a domain found in
many extracellular proteins. The domain typically contains
10 cysteine residues that form ﬁve disulphide bonds in the
combination 1–7, 2–6, 3–5, 4–10 and 8–9. The assumption
that Api m 6 represents a trypsin inhibitor was already
made by Banks & Shipolini (1986), although the protein
was at that time hardly characterized and certainly not yet
named as such. In fact, they described two peptides H1 (17
residues) and H3 (35 residues), which later were found to
correspond with the N-terminal ends of Kettner’s isoforms
of Api m 6, differing from each other only in that one lacks
the ﬁrst four residues. The amino acid compositions were
similar to a protease inhibitor that was earlier puriﬁed from
bee venom by Shkenderov (1973). Although no proteolytic
activity could be assigned to the peptides H1 and H3, it
appears now that Api m 6 has a molecular weight quite near
that of Shkenderov’s protease inhibitor, i.e. 9000 Da.
 
Noncoding sequence variation and the genome assembly
 
A BLASTN search (Altschul 
 
et al
 
., 1997) of the complete
cDNA against honeybee genome assembly 4.0 (Amel_4.0–
20061003) revealed two hits with very high scores/
 
E
 
-values:
scaffold 16.18 (Contig5539), score: 486; 
 
E
 
-value: e-136 and
unmapped scaffold GroupUn.6096 (Contig14926), score: 371;
 
E
 
-value: e-101. DNA sequence comparison demonstrated
a 100% match between Contig5539 (between position 37212
and 36406, introns excluded) and an assembly of the RACE
fragments from 
 
clone 5.1
 
 and 
 
clone 3.9
 
 (Api m 6 variant 1,
Fig. 2A). On the other hand, Contig14926 (between position
16221 and 17048, introns excluded) was identical to the cod-
ing region of the full size Api m 6 transcript and the insert
of 
 
clone 3.3
 
 (Api m 6 variant 2, Fig. 2B). However, the UTR
of the full size cDNA shows an indel of two consecutive
thymines, found upstream from position 41 in DQ384991.
There are also eight indels (at four locations) and one G to
A transition in the 3
 
′
 
 UTR of variant 1 when aligned with var-
iant 2. These results demonstrate the existence of several
different transcript variants of the bee venom allergen Api
m 6, originating from genome-level variation at a single locus.
Api m 6 shows a substantial amount of sequence varia-
tion (nearly all haplotypes sequenced to date differ in at
least one place) as well as sections of repetitive simple
sequences (monobasic A or T runs, as well as an AT dinu-
cleotide repeat; Fig. 1). It is conceivable that this variation
was the root cause for misassembly at this section of the
draft honeybee genome sequence. First, it is evident that
assembly scaffolds 16.18 and GroupUn.6095 are homolo-
gous, and that GroupUn.6095 spans the gap between
Figure 2. Alignment of two in silico spliced honeybee genome sequences with different cDNA fragments of the bee venom allergen Api m 6. (A) Api m 6 was 
present in mapped scaffold 16.18 from genome assembly 4.0 (positions marked above the bar, along with coordinates for the corresponding Contig5339). 
Api m 6 is characterized by two introns (depicted by black triangles; splicing sites given on top) and this haplotype of the genome assembly showed a perfect 
sequence-level match with cloned 5′- (clone 5.1) and 3′-RACE fragments (clone 3.9). The predicted protein from this sequence is identical to the described 
Api m 6 variant 1. (B) A second transcript variant was found by cDNA sequencing (full cDNA). This transcript has a nearly identical match to unmapped scaffold 
GroupUn.6097 (Contig14926), the only difference being a TT-insertion mutation (depicted by a white triangle) in the 5′-UTR. The 3′-end of transcript variant 2 
corresponds also to another cloned 3′-RACE fragment (clone 3.3). Fragment lengths (in bp) are given below the bar and in boxes. 
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assembly scaffolds 16.18 and 16.19. These genome sections
apparently assembled separately because of sequence
variation found in the two haplotypes sequenced for the
Honeybee Genome Project. This effect is probably widespread
in assemblies of this and other draft genome sequences. In
fact, this effect is seen further down chromosome 16 (scaf-
folds 16.11 and 16.12), where the hypervariable immune
effector apidaecin (Casteels 
 
et al
 
., 1994) has apparently
disrupted the genome assembly. An understanding of allelic
variation at speciﬁc genes might help unite unassembled
parts of the bee genome. As a corollary, misassembled
sections of the bee genome might indicate biologically
important variation in genes adjacent to these gaps.
 
Experimental procedures
 
Bee venom glands
 
Honeybees (
 
Apis mellifera carnica
 
) were all taken at the hive
entrance of a single colony from the apiary of the Ghent University
(Belgium). The venom glands of 320 bees were dissected under
anaesthesia by chilling. First, the whole sting apparatus was removed
from the abdomen and submerged in RNALater® (Ambion, Austin,
TX, USA). Subsequently, the glands were separated from the reservoir
and collected all together in 100 
 
µ
 
l fresh solution. Homogenization
and mRNA isolation was done using the Micro-FastTrack™ 2.0
Kit (Invitrogen, Carlsbad, CA, USA) following the protocol for fresh
and frozen tissue. After spectrophotometric yield determination,
mRNA was stored in elution buffer at 
 
−
 
80 
 
°
 
C until ready for use.
 
cDNA preparation and primer development
 
Venom gland cDNA was prepared using AMV reverse transcriptase
and the oligo dT primer from the cDNA Cycle® Kit (Invitrogen)
according to the manufacturer’s instructions. To ﬁnd the corre-
sponding genome sequence for primer development, the Api m 6
amino acid sequence (P83563) was B
 
LAST
 
-searched against an
early release of the honeybee genome (Amel_1.2) at http://
www.hgsc.bcm.tmc.edu/projects/honeybee. The target domain
was located on group 16.4 and extended from position 258118–
258415 (total length of the group: 806 207 bp). Subsequently Api
m 6 gene-speciﬁc primers (GSP) for rapid ampliﬁcation of cDNA
ends (RACE; see further) were developed using the Primer3 software
on the world wide web (Rozen & Skaletsky, 2000). This gave
the following result: GSP forward primer (GSP-fw) 5
 
′
 
-TTGGAG-
GATTTGGAGGCTTGGAGGA-3
 
′
 
 and GSP reverse primer (GSP-rv)
5
 
′
 
-GCATTTAGATCGCGGAACGCATACCT-3
 
′
 
.  Their suitability for
further analysis was tested by a simple polymerase chain reaction
(PCR) using the venom gland cDNA preparation (see above) as
template. The resulting amplicon was sequenced for conﬁrmation.
 
5
 
′
 
-Rapid ampliﬁcation of cDNA ends (5
 
′
 
-RACE) and 3
 
′
 
-RACE
 
RACE ready cDNA was prepared by following the protocol
described in the GeneRacer™ Kit (Invitrogen). Brieﬂy, 100 ng of
bee venom gland mRNA was subsequently treated with calf
intestinal phosphatase and tobacco acid pyrophosphatase, to be
ligated at its 5
 
′
 
-end with the GeneRacer™ RNA oligo. This ligated
mRNA was reverse transcribed using the SuperScript™ III RT and
the GeneRacer™ oligo dT primer to create RACE-ready ﬁrst-strand
cDNA with known priming sites at the 5
 
′
 
- and 3
 
′
 
-ends. Generation
of 5
 
′
 
-RACE fragment was done by PCR, using a combination of
GeneRacer™ 5
 
′
 
-primer and GSP-rv, whereas the 3
 
′
 
-ampliﬁcation
needed a combination of GSP-fw and GeneRacer™ 3
 
′
 
 primer.
Both reactions were done in an Eppe
 
Λ
 
dorf Mastercycler using a
touchdown protocol.
 
Cloning and DNA sequencing
 
PCR products were cloned in the pCR®4-TOPO® vector. Individual
transformants were picked and analysed for the presence of insert by
PCR. The corresponding amplicons were used for sequence analysis.
DNA sequencing was performed using a Perkin Elmer ABI Prism
377 (Perkin Elmer, Wellesley, MA, USA) automated DNA sequencer.
PCR product was treated with shrimp alkaline phosphatase (1 U/
 
µ
 
l,
Amersham E70092Y, Amersham Biosciences, Buckingham, UK)
and exonuclease I (20 U/
 
µ
 
l, Epicentre Biotechniologies 
 
×
 
40505k,
Madison, WI, USA) for 15 min at 37 
 
°
 
C, followed by 15 min at 80 
 
°
 
C
to inactivate the enzymes. This material was then used for cycle
sequencing without any further puriﬁcation, using the ABI Prism
BigDye V 3.1 Terminator Cycle Sequencing kit. The sequencing con-
ditions were 30 s at 96 
 
°
 
C, 15 s at 50 
 
°
 
C and 4 min at 60 
 
°
 
C for 27
cycles. Primers used for sequencing were GSP-fw, GSP-rv or
GeneRacer™ 5
 
′
 
-primer. Cycle sequence products were precipi-
tated by adding 25 
 
µ
 
l of 95% ethanol and 1 
 
µ
 
l 3 
 
M
 
 sodium acetate,
pH 4.6 to each cycle sequencing reaction (10 
 
µ
 
l). The samples
were placed at 
 
−
 
20 
 
°
 
C for 15 min and centrifuged at 14 000 r.p.m.
(12 225 
 
g
 
) for 15 min. After precipitation, an additional wash of the
pellet was performed with 125 
 
µ
 
l of 70% ethanol and centrifuged
at 14 000 r.p.m. (12 225 
 
g
 
) for 5 min. The pellet was dried in a
Speedvac concentrator, redissolved in loading buffer and run on a
48 cm 4.25% acrylamide/bisacrylamide (29 : 1) gel.
 
Analysis of sequence data
 
Partial cDNA clones and the complete cDNA sequence generated
above were aligned with honeybee genome assembly 4.0
(Amel_4.0–20061003) using BLASTN (Altschul 
 
et al
 
., 1997), with-
out ﬁlters. Sequences were also compared by BLASTN with
unscaffolded contigs. Several thousand base pairs of ﬂanking
DNA on either side of Api m 6 (e.g. on Contig5539) was used to
conﬁrm that this contig and unassembled Contig14926 were in fact
derived from the same genome location, despite showing substan-
tial genome sequence variation at and near Api m 6. Unscaffolded
Contig14926 was used, via BLASTN, to span the gap between
assembled scaffolds 16.18 and 16.19. Sequence variation 2 5
 
′
 
-
and 3
 
′
 
 UTR regions of Api m 6 was characterized by alignment of
DQ384991 and Contigs14926 and 5539.
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